At the time of publication, the FDA reviews a Zepbound scarcity resulting from demand increase. There’s confined availability of several doses. The existing shortage is projected to carry on with the 2nd quarter of 2024. Ozempic is usually also prescribed off-label for weight loss in Older people with obesity who https://www.fitnesshealths.com/best-weight-loss-medications/page/2/#quick-view